Skip to content
‹ Back to IndustriesHealthcare

Analyzing the Health Effects of Space Travel with AI

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke  with host Tyler Kern about the movement collaboration…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke with host Tyler Kern about the movement collaboration between Intel and the Frontier Development Lab an applied artificial intelligence research accelerator established to maximize new AI technologies and capacities emerging in academia and space and exploration.

The Intel and Frontier Development Lab collaboration aims to improve the data collection of astronauts. The collaboration is working to make space exploration safer and healthier through artificial intelligence. “The collaboration with Intel rose organically. We were already applying AI and machine learning in the space, specifically for decision making,” says Dr. Kalantari.

“AI, when it comes to terrestrial medicine, is suffering from the same challenges as astronaut health and space medicine,” says Dr. Kalantari, who believes part of the issue is combining the health data of astronauts safely and securely into one database. “To train an AI, you have to bring together all the data into one spot and use that to train the algorithms,” says Shashi Jain.

The risk of spending time in space is detrimental to the human body. According to NASA, when astronauts are in microgravity, the human body loses muscle mass and bone density. Physically and psychologically, the impact on human bodies could be detrimental. The mission could fail if health issues hinder a crew member on a mission.

Currently, the effects on astronauts are similar to how we gather health information on earth. Data is collected through observation and measuring vitals. “We use this collection of data before, during, and after each mission to identify any prominent biomarkers that could be indicators of disease progression,” says Jain. The main challenge of the project is maintaining the privacy of the individuals so that the collected data can train AI for the future.

For more information on the power of technology and the future of astronaut health, connect with Shashi Jain and Dr. John Kalantari on LinkedIn or explore Intel’s Health and Life Sciences page.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Network & Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Access TeleCare pharmacist Ashley Selby describes a telehealth antimicrobial stewardship model sized to each hospital's gaps. Joint Commission Standard MM.09.01.01 and 42 CFR 482.42 require a qualified physician and/or pharmacist leader, not a full-time hire, and a 14-study meta-analysis found telehealth stewardship cut antibiotic days of therapy without changing mortality.

  • 01Joint Commission Standard MM.09.01.01, in force since January 2023, requires a physician and/or pharmacist qualified in infectious diseases or stewardship to lead the program, and its committee note allows remote participation.
  • 02The Board of Pharmacy Specialties counts more than 2,380 BCIDP pharmacists nationally, while many small hospitals still assign stewardship to pharmacists without ID training.
  • 03A 14-study meta-analysis found telehealth stewardship raised guideline adherence and cut antibiotic days of therapy, but did not significantly change mortality.

Nov 9, 2026

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512